Finally, we confirmed that SRPK1 inhibition also alters BRD4 splicing in breast cancer cells (Supplementary Fig. 9o), a finding that may be of therapeutic significance in metastasis prevention12,20. The gene discussed is BRD4; the disease is breast carcinoma.